Oncology in Mozambique: Overview of the Diagnostic, Treatment, and Research Capacity

Autores da FMUP
Participantes de fora da FMUP
- Tulsidas, S
- Brandao, M
- Carrilho, C
Unidades de investigação
Abstract
Simple Summary Mozambique is one of the poorest countries in the world. Because of the limited number of human and material resources, priority is usually given to infectious diseases because they are the main cause of death in Mozambique. However, with the increasing adoption of an unhealthy lifestyle, the number of deaths attributed to cancer is also increasing. This review summarizes cancer incidence and mortality, cancer prevention and screening, cancer care resources, and trends in cancer training and research in Mozambique, providing a background for the development of cancer care policies in the country. Mozambique is one of the poorest countries worldwide, with nearly two thirds of the population living below the poverty line. Similarly to other less developed countries, there is a weak provision of health care for non-communicable diseases due to competing priorities with infectious diseases. Although the leading causes of death in Mozambique in 2019 were Acquired Immune Deficiency Syndrome/Human Immunodeficiency Virus and other sexually transmitted diseases and respiratory infections and tuberculosis, with increasing urbanization and westernization of lifestyles, deaths attributed to cancer are also on the rise. This review summarizes cancer burden, cancer prevention and screening, cancer care resources, and trends in cancer training and research in Mozambique, providing a background for the development of cancer care policies in the country.
Dados da publicação
- ISSN/ISSNe:
- 2072-6694, 2072-6694
- Tipo:
- Review
- Páginas:
- 1163-
- Link para outro recurso:
- www.scopus.com
Cancers Multidisciplinary Digital Publishing Institute (MDPI)
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 4
Documentos
- Não há documentos
Filiações
Keywords
- Mozambique; cancer care facilities; cancer screening; cancer vaccines; developing countries; neoplasm; registry
Proyectos asociados
Breast cancer heterogeneity - etiology, clinical management, use of health resources and survival
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2022
Longitudinal Assessment of Cognitive Decline in Breast and Prostate Cancer Survivors
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico (Cognitive Decline) . 2022
Healthcare use among cancer patients and their partners in different phases of the cancer pathway
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2021
Reshaping organized cervical cancer screening: strategies to increase the adherence and reduce invitation costs
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2020
Using pooled analyses based on individual participant data for a finer assessment of gastric cancer etiology
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2020
RISK AND SURVIVAL OF GASTRIC CANCER RELATES SECOND PRIMARY TUMOURS: A COMPETING RISKS FRAMEWORK
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2019
Citar a publicação
Tulsidas S,Fontes F,Brandao M,Lunet N,Carrilho C. Oncology in Mozambique: Overview of the Diagnostic, Treatment, and Research Capacity. Cancers. 2023. 15(4):p. 1163-1163. IF:5,200. (2).